Amplatzer left atrial appendage occlusion through a patent foramen ovale

Catheterization and Cardiovascular Interventions

Volumn 84, Issue 7, 2014, Pages 1190-1196

  Koermendy, Dezsoe ^a   Nietlispach, Fabian ^a   Shakir, Samera ^a   Gloekler, Steffen ^a   Wenaweser, Peter ^a   Windecker, Stephan ^a   Khattab, Ahmed A ^a   Meier, Bernhard ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Left atrial appendage closure; Patent foramen ovale atrial septal defect; Transseptal catheterization

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

AGED; ARTICLE; CARDIAC PLUG; CARDIOVASCULAR CATHETER; CATHETER SHEATH; FEMALE; FOLLOW UP; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART LEFT ATRIUM; HEMOPERICARDIUM; HUMAN; INTERMETHOD COMPARISON; J WIRE; LEFT ATRIAL APPENDAGE OCCLUSION; MAJOR CLINICAL STUDY; MALE; NONSURGICAL INVASIVE THERAPY; PATENT FORAMEN OVALE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSSEPTAL PUNCTURE; TREATMENT DURATION; VASCULAR ACCESS; VASCULAR OCCLUDER; ATRIAL FIBRILLATION; COMPLICATION; FLUOROSCOPY; FORAMEN OVALE, PATENT; PROCEDURES; SEPTAL OCCLUDER; TREATMENT OUTCOME;

AGED; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CARDIAC CATHETERIZATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FLUOROSCOPY; FOLLOW-UP STUDIES; FORAMEN OVALE, PATENT; HUMANS; MALE; SEPTAL OCCLUDER DEVICE; TREATMENT OUTCOME;

EID: 84912011303     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25354     Document Type: Article

References (17)

1. Sievert H, Lesh MD, Trepels T, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: Early clinical experience. Circulation 2002;105:1887-1889.
2. Meier B, Palacios I, Windecker S, et al. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv 2003;60:417-422.
3. Ostermayer SH, Reisman M, Kramer PH, et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: Results from the international multi-center feasibility trials. J Am Coll Cardiol 2005;46:9-14.
4. Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised noninferiority trial. Lancet 2009;374:534-542.
5. Park JW, Bethencourt A, Sievert H, et al. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: Initial European experience. Catheter Cardiovasc Interv 2011;77:700- 706.
6. Lam YY, Yip GW, Yu CM, et al. Left atrial appendage closure with Amplatzer cardiac plug for stroke prevention in atrial fibrillation: Initial Asia-Pacific experience. Catheter Cardiovasc Interv 2012;79:794-800.
7. Nietlispach F, Gloekler S, Khattab A, et al. Percutaneous left atrial appendage closure. Eur J Geriatric Med 2012;3:308- 311.
8. Nietlispach F, Gloekler S, Krause R, et al. Amplatzer left atrial appendage occlusion: Single center 10-year experience. Catheter Cardiovasc Interv 2013;82:283-289.
9. Gangireddy SR, Halperin JL, Fuster V, et al. Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: An assessment of net clinical benefit. Eur Heart J 2012;33:2700-2708.
10. Reddy VY, Holmes D, Doshi SK, et al. Safety of percutaneous left atrial appendage closure: Results from the Watchman left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the continued access registry. Circulation 2011;123:417-424.
11. Roelke M, Smith AJ, Palacios IF. The technique and safety of transseptal left heart catheterization: The Massachusetts general hospital experience with 1, 279 procedures. Catheter Cardiovasc Diag 1994;32:332-339.
12. McGinty PM, Smith TW, Rogers JH. Transseptal left heart catheterization and the incidence of persistent iatrogenic atrial septal defects. J Interv Cardiol 2011;24:254-263.
13. Viles-Gonzalez JF, Kar S, Douglas P, et al. The clinical impact of incomplete left atrial appendage closure with the Watchman device in patients with atrial fibrillation: A PROTECT AF (percutaneous closure of the left atrial appendage versus Warfarin therapy for prevention of stroke in patients with atrial fibrillation) substudy. J Am Coll Cardiol 2012;59: 923-929.
14. Zaker-Shahrak R, Fuhrer J, Meier B. Transseptal puncture for catheter ablation of atrial fibrillation after device closure of patent foramen ovale. Catheter Cardiovasc Interv 2008;71: 551-552.
15. Meier B, Kalesan B, Mattle HP, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. New Engl J Med 2013;368:1083-1091.
16. Carroll JD, Saver JL, Thaler DE, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. New Engl J Med 2013;368:1092-1100.
17. Wahl A, Jeuni P, Mono ML, et al. Long-term propensity scorematched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism. Circulation 2012;125:803-812.